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ABSTRACT:
Aims: Serial photographs have been collected prospectively to evaluate the effect of radiotherapy on normal tissues in
the breast. The aim of this study was to compare two methods of scoring radiation-induced changes.
Materials and methods: Five-year photographs of 400 patients randomised to receive either 42.9 or 39 Gy in 13
fractions to the whole breast after tumour excision of early breast cancer were compared with a post-surgery baseline
and scored for change in breast appearance on a three-point graded scale. Two alternative methods of scoring using
three observers were compared: (a) scores allocated independently, with independent resolution of discrepancies, and
(b) scores allocated by consensus.
Results: Treatment effects estimated from the consensus and independent scores were very similar (odds ratio 1.89,
95% confidence interval 1.21e2.96 vs 2.28, 95% confidence interval 1.50e3.47, respectively). Agreement between the
scores obtained from each method was reasonable, and the repeatability of the consensus method was good.
Conclusions: The consensus method of scoring photographic change in breast appearance seems to be no less sensitive
to randomised dose as the independent method of assessment, but is much quicker to administer. The consensus method
has been used to score over 3000 sets of photographs in the National Cancer Research Institute Standardisation of Breast
Radiotherapy trial. Haviland, J. S. et al. (2008). Clinical Oncology 20, 497—501
ª 2008 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
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Introduction
The outcome of tumour excision and radiotherapy on the
preserved breast in women with early breast cancer has
been recorded using a graded cosmetic scale (excellent,
good, fair, poor) applied by the treating clinician [1e4].
Cosmesis as an aesthetic judgement is certainly relevant,
but is only valid when scored by patients than by external
observers [5,6]. It is a valuable global outcome for judging
the overall success or failure of surgery and radiotherapy,
but it is not the most sensitive end point of radiation
adverse effects [7]. This is because radiation effects are
not the only factors influencing the breast cosmesis score,
as surgical deficit, scar appearance and the woman’s
expectations are also important.
Serial photographs scored by external observers using
objective criteria in comparisonwith a post-surgical baseline
image have been used to score radiotherapy adverse effects
for many years [8e13]. The precise methodology has varied,
with some investigators projecting a calibrated grid onwhich
objective linear measurements can be collected [8]. The
post-surgical baseline photograph of the contralateral breast
is needed to control for time-dependent changes unrelated
to radiotherapy, including weight gain and effects of ageing.
After allowance for these and surgical deficit in the treated
breast, any additional changes in the treated breast are
attributed to radiotherapy.
A change in breast appearance scored from photographs
was the primary end point for the Royal Marsden Hospital/
Gloucestershire Oncology Centre (RMH/GOC) trial of alter-
native fractionation regimens in women treated by breast
conservation surgery and radiotherapy for early breast
cancer [14]. The results of this randomised trial confirmed
that changes in breast appearance scored from annual
photographs compared with post-surgical baseline photo-
graphs provide a measure of late radiation change that is
sensitive to a 10% difference in radiotherapy fraction size.
In this trial, dedicated evaluation sessions were held, which
required three observers to each independently score
follow-up photographs. Discrepancies between observers
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were re-scored independently. This method of scoring
photographic change in breast appearance was assessed
for reliability and repeatability, and scored highly using the
kappa statistic. All results relating to the RMH/GOC trial
have been published using these data [14].
A change in breast appearance, as assessed by photo-
graphs, was an important secondary end point in the
National Cancer Research Institute (NCRI) Standardisation
of Breast Radiotherapy (START) trial, which tested alter-
native fractionation regimens in 4451 women with early
breast cancer [15]. In the START trial, more than 2000
women were recruited after breast-preserving surgery into
a photographic sub-study, in which photographs were taken
before radiotherapy and at 2 and 5 years. At a median
follow-up of 5 years overall, the challenge of scoring more
than 3000 pairs of photographs using the methodology used
in the previous trial raised logistical difficulties. The
original method was very time-consuming, due to indepen-
dent re-scoring of discrepancies followed by a discussion to
reach consensus if re-scoring did not achieve concordance.
For this reason, an alternative non-independent scoring
system was proposed, whereby three observers conferred
and agreed a score by consensus, without making prior
independent assessments. Apart from routine monitoring of
reproducibility by testeretesting of a random sample, each
pair of photographs was assessed only once, with consider-
able time saving. In order to test this simplified method,
a subset of the RMH/GOC fractionation trial photographs
was re-scored using the consensus method, to test if the
treatment effect found using the independent scoring
method could be reproduced. If so, the consensus method
would be used for assessments of change in breast
appearance from photographs in the NCRI START trial.
Materials and Methods
Details of the RMH/GOC trial have been published
elsewhere [14]. Briefly, between 1986 and 1998, 1410
patients were enrolled and randomised to receive one of
three radiotherapy regimens after local tumour excision of
early stage breast cancer. The control schedule was 50 Gy
in 25 fractions, and the two test schedules were 39 or
42.9 Gy in 13 fractions of 3.0 or 3.3 Gy, all delivered over
5 weeks. The primary end point was change in breast
appearance, obtained from a comparison of photographs
taken after surgery and during follow-up.
Photographic Assessments of Change
in Breast Appearance
Frontal photographs of both breasts were taken under
standard conditions after primary surgery, before radio-
therapy, and repeated annually for 5 years and then at 10
years. Two photographs were taken of the patient’s trunk
region, one with the hands resting on the hips, the other
with the arms raised above the head. Follow-up photo-
graphs were terminated in the case of local relapse, further
breast surgery, declining health or patient refusal.
Photographs were scored under standardised conditions
by three observers blind to patient identity, fractionation
allocation and year of follow-up. Comparisons were always
based on photographs at two time points, one showing
postoperative appearance and the other showing breast
appearance at a later time point. Changes in the contra-
lateral breast made it possible to distinguish radiotherapy
effects from other time-related changes. A change in
breast appearance compared with the postoperative
baseline was scored on a three-point graded scale (none/
minimal¼ 0, mild¼ 1, marked¼ 2) based on a change in
breast size, mainly shrinkage and distortion (Fig. 1). Each
scoring session began with a training set of photographs
to ensure standardisation of scoring criteria between
observers.
Independent Scoring Method
Each of the three observers (two oncologists [JRO and JY]
and one nurse specialist [AA/BB]) independently allocated
a score (three-point scale described above) for a change in
breast appearance. Where there was a discrepancy, the
photographs were again scored independently, together
with an additional random subset (about 10% of the whole
series) to investigate repeatability. No information on
original scores was provided when discrepancies and the
10% random subset were re-scored. When the discrepancy
persisted, the modal category was chosen and in cases
where no modal category was obvious, observers were
asked to reach a consensus by open discussion.
Consensus Scoring Method
A score for a change in breast appearance was allocated by
consensus between three conferring observers (two radia-
tion oncologists [DT and JY], and one trial co-ordinator
[LG]). Taking it in turns, one observer offered a grading that
the other two observers either accepted or challenged. If
challenged, discussion followed until consensus was
reached. The same three-point graded scale was used as
in the independent method. A random 10% subset was re-
scored on the same day as the initial consensus scores in
order to test for repeatability.
Sample Size
In the RMH/GOC trial, the main treatment comparison of
interest was between the two experimental fractionation
schedules (i.e. 39 and 42.9 Gy in 13 fractions). For the
purposes of verifying the treatment effect, it was not
considered informative to re-score photographs in women
allocated 50 Gy. The largest prevalence of change in breast
appearance in the RMH/GOC trial was at 5 years, and the
treatment effect obtained at 5 years was similar to that
obtained from survival analysis across all photographic
assessments. Hence, the re-scoring focussed on year 5
photographs. From the previous data obtained using the
independent scoring method, rates of change (mild and
marked) in breast appearance at 5 years were 35.5% (95%
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confidence interval 29.8e41.7) in the 42.9 Gy group and
19.4% (95% confidence interval 14.9e24.9) for 39 Gy (odds
ratio 2.28, 95% confidence interval 1.50e3.47). Two hundred
patients per group (total 400) would enable the treatment
effect to be estimated to within a similar degree of precision
(95% confidence interval for odds ratio 1.45e3.60).
Because the consensus scoring was carried out at RMH
and the photographs were stored locally at each of the
centres (RMH and GOC), most of the sample was taken from
RMH patients, for convenience. All RMH patients treated
with 42.9 or 39 Gy and with baseline and 5-year photo-
graphs available were included. The remainder of the
sample was randomly selected from eligible GOC patients.
Statistical Methods
Given the limitations of the available sample size, the aim
of this analysis was not to test for a significant difference
between the treatments within the RMH/GOC trial, but to
compare the estimates of treatment effect obtained using
the two scoring methods. The effect of fractionation
schedule on the change in breast appearance at 5 years
was estimated by calculating an odds ratio together with
a 95% confidence interval. Pairs of scores obtained from the
consensus and independent methods were compared within
patients and the weighted kappa statistic calculated as
a measure of agreement. The test of symmetry [16] was
used to test whether one method produced higher scores
for change in breast appearance compared with the other
method of assessment.
Results
Four hundred year 5 photographs were scored by three
observers reaching consensus by open discussion for
a change in breast appearance compared with the post-
surgical baseline. The pairwise scores using the indepen-
dent and consensus methods are shown in Table 1. The
totals in the table show that mild and marked changes in
breast appearance were scored in 88 (22.0%) and 16 (4.0%)
patients using the independent method compared with 97
(24.2%) and 32 (8.0%) using the consensus method,
respectively. Any change in breast appearance (mild or
marked) at 5 years was recorded using the consensus scores
in 77 (39.3%, 95% confidence interval 32.5e46.5) and 52
(25.5%, 95% confidence interval 19.8e32.1) patients rand-
omised to 42.9 and 39 Gy in 13 fractions, respectively. The
odds ratio for change in breast appearance at 5 years for
42.9 Gy vs 39 Gy was 1.89 (95% confidence interval
1.21e2.96), which compared favourably with the treatment
effect estimated using independent observers (odds ratio
2.28, 95% confidence interval 1.50e3.47).
A comparison of the consensus scores with independent
scores showed an observed agreement of 77.2%, with
Fig. 1 e Serial photographs taken after surgery and before radiotherapy (top) and during follow-up (bottom) illustrating: (a) no change in
breast appearance (60 months post-RT right breast) and (b) a marked change in breast appearance (30 months post-RT left breast).
499SCORING NORMAL TISSUE EFFECTS AFTER BREAST RADIOTHERAPY
Author's personal copy
a weighted kappa statistic of 0.56, indicating ‘moderate
agreement’. Similar levels of agreement were obtained for
each of the fractionation schedules, with weighted kappa
statistics of 0.56 and 0.53 for 42.9 and 39 Gy, respectively.
Overall, it seems that a change in breast appearance (mild
or marked) was scored more frequently using the consensus
method, although numbers of marked events in particular
were small. From Table 1 it can be seen that 26 pairs of
photographs (6.5% of 400) were scored less severely using
the consensus method compared with the independent
method (i.e. numbers above the diagonal in the table) and
65 (16.2%) more severely (i.e. numbers below the
diagonal). The test of symmetry was highly significant (c2 ¼
19.5, df¼ 3, P! 0.001), indicating that the distributions of
scores in the table were not symmetric, with higher scores
for a change in breast appearance using the consensus
method. All except two of the discrepancies between the
methods differed by only one category. For these two
patients, their 5-year scores were checked against scores
allocated for years 1e4, and the consensus score was found
to be more consistent with previous years than the
independent score. A random 10% subset of RMH patient
photographs was re-scored in order to test for repeatability
of the consensus method. This showed good agreement
(86.2%), with a weighted kappa statistic of 0.77.
Discussion
Assuming an a/b value of 3 Gy for a late change in breast
appearance, 39 and 42.9 Gy in 13 fractions over 5 weeks are
equivalent to 46.8 and 54 Gy, respectively, in 2.0 Gy
equivalents. The odds ratio of about 2 for a change in
breast appearance over this range of dose intensity is
a vivid reminder of the steepness of the doseeresponse
curve for late adverse effects, representing a g-value of 1.8
[14]. The magnitude of treatment effect obtained using the
consensus method of scoring a change in breast appearance
from photographs was slightly less than that based on the
original independent scores. When three observers
conferred, the odds ratio for a radiation-induced change
in breast appearance after 42.9 Gy vs 39 Gy in 13 fractions
was 1.89 compared with 2.28 when observers scored
independently. These ratios of effect fall within the same
range (95% confidence interval 1.21e2.96 vs 1.50e3.47,
respectively), suggesting that the consensus method of
scoring photographic change is no less sensitive to
randomised dose than the independent method. Although
there are possible explanations for differences in scores
between the two methods, these are unlikely to affect the
odds ratio estimate of treatment effect as all assessments
were carried out blind to radiotherapy schedule.
Agreement between the sets of scores obtained using the
two methods was reasonable, and the consensus method
showed a high level of repeatability between repeat scores.
However, there was evidence of photographs being allo-
cated higher scores for a change in breast appearance using
the consensus method. The scoring of independent and
consensus sets was separated by more than 3 years, and it is
possible that despite training sessions to ensure that the
same criteria were applied, some differences nevertheless
remained. It is possible that thresholds for scoring late
normal tissue effects have changed over the years, as fewer
and milder effects are generally seen nowadays due to
improvements in radiotherapy planning and delivery.
Therefore, this might lead to changes in breast appearance
being assessed as more marked using current expectations,
compared with a few years ago. It should be noted that only
one (JY) of the three observers contributed to both
independent and consensus scores. In the consensus
scoring, a female (DT) replaced a male (JRO) radiation
oncologist and a female trial co-ordinator (LG) replaced
a female nurse oncologist (AA/BB). However, a comparison
of JY’s original independent scores with the consensus
scores showed a similar level of agreement (weighted
kappa¼ 0.54) as for the comparison with the final score
obtained from all three independent observers (weighted
kappa¼ 0.56). This indicates that any differences between
the independent and consensus scores are unlikely to be
due to a change in observers.
Analysis of the time taken to score the photographs
confirmed that the consensus method is quicker, allowing
an average of over 150 assessments per hour compared with
less than 100 per hour using the independent method. This
difference underestimates the savings in time, as, using the
independent scoring method, any discrepancies require
photographs to be recalled for re-scoring, and recalled
once again if the scores are still discrepant at the second
review. The independent method also uses a computer
program in which the three sets of scores are entered in
batches during the sessions, and which generates lists of
discrepancies to be re-scored, thereby adding to the
administrative complexity. Data from the original indepen-
dent scoring sessions for all follow-up photographs from the
trial show that the system of re-scoring discrepancies leads
to an increase in the total number of assessments required
per photograph of 40% overall.
Whichever scoring method is adopted in the current
context, it is important to start with a training set of
photographs that show the full range of treatment effects
and to agree criteria for grading change. The first factor to
allow for is the surgical deficit, using the contralateral
Table 1 e Comparison of scores for change in breast appearance
at 5 years after radiotherapy obtained using independent and
consensus methods: 400 patients randomised into a breast
radiotherapy fractionation trial
Consensus score
Independent score Total for
consensus score
(column %)None Mild Marked
None 248 23 0 271 (67.7)
Mild 46 48 3 97 (24.2)
Marked 2 17 13 32 (8.0)
Total for
independent
score (row %)
296 (74.0) 88 (22.0) 16 (4.0) 400 (100)
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breast in the baseline photograph as a control. Subsequent
weight change or age-related changes are also controlled
by reference to the contralateral breast. As mentioned in
the Materials and Methods section, the most obvious and
frequent change is breast shrinkage, presenting as a loss of
volume affecting the whole organ. A change in post-surgical
breast shape (distortion) with time may be seen in addition
to a loss of volume, a reliable indicator of underlying
fibrosis. Either way, one of the key indicators of volume loss
and/or distortion is nipple displacement. A shift in the
position of the nipple has been successfully used as the
basis for scoring treatment outcome in other published
photographic scoring systems [8,10e12,17]. Linear
measurements of nipple displacements can be collected
from photographs in an objective and reproducible manner.
However, the current analysis suggests that a subjective
assessment of change can also be applied very quickly in
a reproducible manner to detect small differences in
radiotherapy dose.
Although telangiectasia is easily seen on exposed
surfaces of the breast, it is usually confined to the
inframammary fold of heavy-breasted women, where it
reflects loss of skin sparing. Telangiectasia was, therefore,
not considered in scoring the photographic phenotype. In
patients with a marked change in breast appearance, the
skin frequently looks shiny, a difference interpreted as
evidence of skin dryness and atrophy. Although not formally
included in the scored phenotype, this change in appear-
ance is a common feature in women with marked breast
shrinkage and/or distortion. Other important elements of
the late radiation effects that cannot be scored from
photographs include breast induration (assumed to repre-
sent fibrosis) and underlying damage to muscle, ribs, lungs
or heart. These require additional assessments, including
simple palpation.
In conclusion, the logistics of the consensus method far
outweigh the original independent method in terms of time
taken and ease of recording scores. Since this validation
study was carried out, a team of three (JRO, JY, LG) has
scored change in breast appearance from the photographs
taken in the NCRI START trial using the consensus method.
It is proposed that the new method will be used for all
photographic assessments of change in breast appearance
in future radiotherapy trials.
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